These data support a model whereby hyperactive lysosomal catabolism and Wnt activity maintain a continuous degradation of PDXK protein, which could be linked to the vitamin B6 deficiencies that are prevalent across patients with CRC. The gene discussed is PDXK; the disease is colorectal carcinoma.